Colorectal Cancer Update Patient Perspectives on Colorectal Cancer

Slides:

Advertisements

Similar presentations

Progress Against Stomach Cancer. 1980–1989 Progress Against Stomach Cancer 1980– : Combination chemotherapy improves outcomes for advanced stomach.

Advertisements

Progress Against Pancreatic Cancer. 1970–1979 Progress Against Pancreatic Cancer 1970– s: Tobacco use found to cause pancreatic cancer.

Neoadjuvant therapy for Rectal cancer

What is the treatment?. For the Patient Chemotherapy- initial Enucleation- if unsuccessful.

Advances and Emerging Therapy for Lung Cancer

DEBATE: What is the Optimal Sequence of Therapies for Stage II-III Adenocarcinoma of the Proximal Stomach? Michael A. Choti, MD Department of Surgery UT.

MOSAIC Stage ll+lll FOLFOX4 LV5FU2 Randomize. DFS DFS (months) Hazard ratio: 0.77 [0.65 – 0.92] p < 0.01 FOLFOX (n=1123) 77.9% LV5FU2 (n=1123) 72.8% FOLFOX.

A Phase III Trial Comparing FULV to FULV + Oxaliplatin in Stage II or III Carcinoma of the Colon: Results of NSABP-C-07 Norman Wolmark, MD Colorectal Cancer.

Aakash H. Gajjar, MD, FACS Assistant Professor of Surgery Colon & Rectal Surgery University of Texas Medical Branch Galveston, Texas February 10 th, 2014.

Colon Cancer Basic Science 9/21/05. Colon and rectal neoplasms are characterized by: Consist of the third most common site of new cancer cases and deaths.

62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.

Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,

Colon Cancer Colon Cancer By: Ryan Feldt What is Colon Cancer? What is Colon Cancer? n A disease in which cancer cells are found in the tissue of the.

Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.

By Craig Magnus.  Growing rapidly to become one of the most deadliest diseases in the US, lung cancer makes up nearly one quarter of all deaths per year.

U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only.

Eleni Galani Medical Oncologist

Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.

Colon Cancer Daniel A. Nikcevich, MD, PhD Duluth Clinic Cancer Center January 26, 2009.

Vascular issues associated with bevacizumab Stuart M. Lichtman, MD, FACP 65+ Clinical Geriatric Program Associate Attending Memorial Sloan-Kettering Cancer.

Colorectal carcinoma Dr.Mohammadzadeh.

Colon Cancer First Page.

Patterns of Care in Medical Oncology Neoadjuvant and Adjuvant Treatment of Rectal Cancer.

Treatment options depend on the following: – The stage of the cancer – Whether the cancer has recurred – The patient’s general health.

Session Fertility and Pregnancy FL-BBM Specific questions Risk of premature ovarian failure Ability to become pregnant Safety of pregnancy.

Oxaliplatin/5FU/LV in adjuvant colon cancer: Updated efficacy results of the MOSAIC trial, including survival, with a median follow-up.

IBS, ABS….AND ABS? GP EDUCATION NIGHT 25 TH FEB 2015 DR KATRIN (New trials, new drugs and good advice)

COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.

Colon Rectum x1.85x2.35x1.87x2.48 1:111:8 1:11.

File #1 Table of Contents Introduction Presenter’s Notes Oncology Rehabilitation: Web-based Learning for Physical Therapists Who Provide Rehabilitation.

Patterns of Care in Medical Oncology Adjuvant Systemic Therapy for Colon Cancer.

Genomic Health, Inc. Yuko Soneoka, Ph.D., J.D. Senior Corporate Counsel, IP Director of Intellectual Property January 31, 2013.

The Colorectal Cancer Center Jena Gharbi A, Settmacher U. Department of General, Visceral and Vascular Surgery, Friedrich-Schiller-University Jena

T Andre, E Quinaux, C Louvet, E Gamelin, O Bouche, E Achille, P Piedbois, N Tubiana-Mathieu, M Buyse and A de Gramont. Updated results at 6 year of the.

Adjuvant chemotherapy – When should surgeons recommend? Joint Hospital Surgical Grand Round Dr Lorraine Chow Ruttonjee Hospital.

Which Adjuvant Systemic Treatments Would Medical Oncologists Wish to Receive If They Had Colon Cancer? A Survey of 150 Physicians N Love, MD 1 ; NJ Meropol,

LCC REC-1 Φ π π π Φ Φ See Primary and Adjuvant Treatment (LCC REC-3) Observe or See Primary Treatment (LCC REC-3) Rectal Cancer.

Colorectal Cancer Update Patient Perspectives on Colorectal Cancer Section 2 The Initial Diagnosis, Consultation with a Medical Oncologist.

How Well Do We Communicate with Patients Concerning Adjuvant Systemic Therapy? A Survey of 150 Colorectal Cancer Survivors Neil Love, MD 1 ; Carma Bylund,

Scott Kopetz, MD, PhD Department of Gastrointestinal Medical Oncology

Colorectal Cancer Update Patient Perspectives on Colorectal Cancer Section 6 Patient Grading of their Physicians, Patient Education Needs.

Patterns of Care in Medical Oncology Treatment of Metastatic Colon Cancer.

Results Abstract Analysis of Prognostic Web-based Models for Stage II and III Colon Cancer: A Population-based Validation of Numeracy and Adjuvant! Online.

SATMathVideos.Net A) only I B) only II C) II and III D) I, II and III If two sides of a triangle have sides of lengths 4 and 7, the third leg of the triangle.

LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.

Screening – a discussion in clinical preventive medicine Galit M Sacajiu MD MPH.

Neoadjuvant FOLFOX with Bevacizumab but without Pelvic Radiation for Locally Advanced Rectal Cancer Schrag D et al. Proc ASCO 2010;Abstract 3511.

Colorectal cancer Clinical case scenarios Mixed chemotherapy treatment options Educational Resource February 2012 Updated January 2015 NICE clinical guideline.

종양혈액내과 R4 고원진 / pf. 김시영 Rectal cancer : state of the art in 2012 Curr Opin Oncol 2012, 24:441–447.

CCO Independent Conference Highlights

Schema of the NSABP B-34 trial evaluating adjuvant oral clodronate in patients with resected stage I and II operable breast cancer (Chemo, adjuvant chemotherapy;

VEGF and VEGFR1 Gene expression levels predict tumor recurrence in adjuvant colon cancer Yan Ning1, Georg Lurje1, Kathleen Danenberg2, Janine Cooc2, Dongyun.

Which Adjuvant Systemic Treatments Would Medical Oncologists Wish to Receive If They Had Colon Cancer? A Survey of 150 Physicians N Love, MD1; NJ Meropol,

A Paradigm Shift From One-Size-Fits-All to Tailor-Made Therapy for Metastatic Colorectal Cancer.

تهیه کننده: استاد مربوطه: بهار 1392

Colon Cancer Stages I-III

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.

Volume 117, Issue 4, Pages (October 1999)

MJ O’Connell for the ACCENT Collaborative Group

Volume 141, Issue 1, Pages (July 2011)

Neoadjuvant Adjuvant Curative Palliative

The 10-year cumulative incidence of CRC death or death due to other causes in patients treated with adjuvant chemotherapy after surgery for stages II–III.

Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) +/- cetuximab for patients with untreated metastatic adenocarcinoma of the.

and the NSABP Investigators

Colorectal Cancer in Older Patients Key Issues

The best response for target lesions per patient for patients with target lesions assessed at baseline and at least 1 follow-up. The best response for.

Epithelial and stromal percentage clusterin staining in normal nonadjacent colonic tissue and matched tumor tissue in 202 patients with stage II colorectal.

624. Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results Molecular.

Presentation transcript:

Colorectal Cancer Update Patient Perspectives on Colorectal Cancer CRC_PatientPerNEW_Sec3_v5es.ppt 7/2/2018 Colorectal Cancer Update Patient Perspectives on Colorectal Cancer Section 3 Risks and Benefits of Adjuvant Chemotherapy

Audio CD Segment 2. Potential Benefits of Adjuvant Chemotherapy for Stage III Tumors To what extent were you able to understand the discussion you just heard? 16% 84% I understood it completely I understood most of it

Audio CD Segment 2. Potential Benefits of Adjuvant Chemotherapy for Stage III Tumors To what extent are you interested in the discussion you just heard? 7% 71% 22% Extremely interested Very interested Somewhat interested

Audio CD Segment 2. Potential Benefits of Adjuvant Chemotherapy for Stage III Tumors How valuable is this information to a patient with colorectal cancer? 9% 11% Extremely interested 80% Very interested Somewhat interested

Audio CD Segment 3. Potential Benefits of Adjuvant Chemotherapy for Stage II Tumors To what extent were you able to understand the discussion you just heard? 25% 75% I understood it completely I understood most of it

Audio CD Segment 3. Potential Benefits of Adjuvant Chemotherapy for Stage II Tumors To what extent are you interested in the discussion you just heard? 8% 72% 20% Extremely interested Very interested Somewhat interested

Audio CD Segment 3. Potential Benefits of Adjuvant Chemotherapy for Stage II Tumors How valuable is this information to a patient with colorectal cancer? 4% 81% 15% Extremely valuable Very valuable Somewhat valuable

Audio CD Segment 4. Side Effects and Complications of Adjuvant Chemotherapy To what extent were you able to understand the discussion you just heard? 8% 65% 27% I understood it completely I understood most of it I understood some of it

Audio CD Segment 4. Side Effects and Complications of Adjuvant Chemotherapy To what extent are you interested in the discussion you just heard? 14% 62% 24% Extremely interested Very interested Somewhat interested

Audio CD Segment 4. Side Effects and Complications of Adjuvant Chemotherapy How valuable is this information to a patient with colorectal cancer? 8% 19% Extremely valuable 73% Very valuable Somewhat valuable

After Hearing This Discussion and Considering Any Other Information or Experiences You Have Had in the Past, at This Point, If You Had a Friend or Loved One in Their Sixties, in Relatively Good Health but with Colon Cancer, Which Chemotherapy Would You Recommend? Stage II 68% 21% 10% 1% FOLFOX Capecitabine 5-FU/leucovorin None Stage III 87% 6% 6% 1%

What Would Be the Minimum Reduction in the Chance That Your Cancer Would Come Back in Five Years You Would Require to Undergo Therapy with FOLFOX? * 1 out of every 100 people would benefit.

CRC_PatientPerNEW_Sec3_v5es.ppt 7/2/2018 Based on the Discussions You Just Heard, in General, How Problematic Do You View the Following Side Effects? (1 = Not a Problem; 5 = Major Problem) Percent answering 4 or 5 ®